Table 3.
Comparisons of EGFR-TKI exposure time
| Months | EGFR-TKI, n (%) | Chemotherapy + EGFR-TKI, n (%) |
|---|---|---|
| t>18 | 16 (51.61) | 16 (50) |
| 12< t ≤18 | 9 (29.03) | 7 (21.87) |
| 6< t ≤12 | 6 (19.35) | 9 (28.13) |
Abbreviation: TKI, tyrosine kinase inhibitor.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.